Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABOVE: Isoflurane vs IV Sedation in Pediatric Critically Ill Patients
NCT05867472Phase 3Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Oct 2023
- Primary completion
- May 2026
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of isoflurane in delirium, sponsored by Sunnybrook Health Sciences Centre. Started Oct 2023; status: recruiting.
02
Drugs
isoflurane
03
Conditions
delirium
Beyond the preview
Go deeper on NCT05867472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05867472.